Swiss National Bank Amphastar Pharmaceuticals, Inc. Transaction History

Swiss National Bank

$150 Billion
Q3 2024

A detailed history of Swiss National Bank transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Swiss National Bank holds 76,400 shares of AMPH stock, worth $3.41 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

76,400

Previous 77,000 0.78%

Holding current value

$3.41 Million

Previous $3.08 Million 20.36%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$36.99 - $50.09 $22,194 - $30,054	-600 Reduced 0.78%	76,400 $3.71 Million
Q2 2024 Aug 08, 2024	BUY	$38.65 - $43.48 $54,110 - $60,871	1,400 Added 1.85%	77,000 $3.08 Million
Q1 2024 May 07, 2024	SELL	$42.85 - $63.45 $64,275 - $95,175	-1,500 Reduced 1.95%	75,600 $3.32 Million
Q4 2023 Feb 06, 2024	SELL	$44.49 - $62.93 $347,022 - $490,854	-7,800 Reduced 9.19%	77,100 $4.77 Million
Q3 2023 Nov 08, 2023	BUY	$45.51 - $65.0 $40,959 - $58,500	900 Added 1.07%	84,900 $3.9 Million
Q2 2023 Aug 09, 2023	BUY	$35.77 - $58.38 $21,462 - $35,028	600 Added 0.72%	84,000 $4.83 Million
Q1 2023 May 10, 2023	SELL	$27.99 - $37.92 $313,488 - $424,704	-11,200 Reduced 11.84%	83,400 $3.13 Million
Q4 2022 Feb 08, 2023	BUY	$27.93 - $31.27 $55,860 - $62,540	2,000 Added 2.16%	94,600 $2.65 Million
Q3 2022 Nov 09, 2022	BUY	$27.56 - $37.75 $57,876 - $79,275	2,100 Added 2.32%	92,600 $2.6 Million
Q1 2022 May 09, 2022	BUY	$22.96 - $36.45 $153,832 - $244,215	6,700 Added 8.0%	90,500 $3.25 Million
Q2 2021 Aug 06, 2021	SELL	$17.11 - $20.92 $35,931 - $43,932	-2,100 Reduced 2.44%	83,800 $1.69 Million
Q4 2020 Feb 05, 2021	BUY	$17.76 - $21.24 $35,520 - $42,480	2,000 Added 2.38%	85,900 $1.73 Million
Q2 2020 Aug 05, 2020	BUY	$14.25 - $22.46 $229,425 - $361,606	16,100 Added 23.75%	83,900 $1.88 Million
Q4 2019 Feb 06, 2020	BUY	$17.07 - $20.64 $27,312 - $33,024	1,600 Added 2.42%	67,800 $1.31 Million
Q3 2019 Nov 12, 2019	BUY	$19.12 - $22.62 $34,416 - $40,716	1,800 Added 2.8%	66,200 $1.31 Million
Q2 2019 Aug 02, 2019	BUY	$18.92 - $22.96 $26,488 - $32,144	1,400 Added 2.22%	64,400 $1.36 Million
Q1 2019 May 10, 2019	BUY	$19.46 - $25.28 $25,298 - $32,864	1,300 Added 2.11%	63,000 $1.29 Million
Q2 2018 Aug 09, 2018	SELL	$14.63 - $19.6 $68,761 - $92,120	-4,700 Reduced 7.08%	61,700 $942,000
Q4 2017 Feb 07, 2018	BUY	$17.76 - $19.75 $124,320 - $138,250	7,000 Added 11.78%	66,400 $1.28 Million
Q3 2017 Nov 03, 2017	BUY	$14.73 - $17.99 $874,962 - $1.07 Million	59,400	59,400 $1.06 Million

Others Institutions Holding AMPH

# of Institutions

287

Shares Held

35.1M

Call Options Held

74.3K

Put Options Held

22.3K

View Full List

About Amphastar Pharmaceuticals, Inc.

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $2.19B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

More about AMPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Amphastar Pharmaceuticals, Inc. Transaction History